Skip to main content
Not investment advice. Educational platform. See Disclaimer.
NASDAQ: NAUT

Nautilus Biotechnology, Inc.

Healthcare | Biotechnology

No licensed closing price on file for NAUT. This page shows the company’s SEC filings and filed figures, without a price or any ratio that depends on one.

Nautilus Biotechnology, Inc. (NASDAQ: NAUT) is a biotechnology company. Figures from SEC EDGAR; updated 2026-10-20 18:44 UTC.

What Nautilus Biotechnology, Inc. does

Nautilus Biotechnology was formed through a business combination completed on June 9, 2021, when ARYA Sciences Acquisition Corp III merged with Legacy Nautilus Biotechnology, Inc., with the combined company taking the name Nautilus Biotechnology, Inc. The company's stock began trading on Nasdaq in June 2021 and transferred to the Nasdaq Capital Market in October 2025.

Summarized from Nautilus Biotechnology, Inc.’s SEC filings · AI-generated analysis. Not investment advice. May contain errors. · Read the filing ↗

Key facts

Charts

Charts are in the appInteractive charts for NAUT are available in Oxford Ledge.
Open NAUT in Oxford Ledge →

SEC Filings

SEC EDGAR ↗
Recent Insider Activity
Source: SEC EDGAR · Filed 2026-06-22
Most recent filed transactions — June 2026:
  • 2026-06-22DirectorStock Option (Right to Buy)Award45,000—
  • 2026-06-22DirectorStock Option (Right to Buy)Award45,000—
  • 2026-06-22DirectorStock Option (Right to Buy)Award45,000—
Sign in to see all transactions →

Company news

View all →
For you

Charts, 10-year financials, peer comparison, screening and portfolio tracking for NAUT and 5,000+ tickers.

Create a free account — keep NAUT
For your agent
GET /api/data?ticker=NAUT

This page as JSON via rel="alternate" · REST API docs · MCP server (60 tools) · llms.txt